Prestige Biologics Co., Ltd. (KOSDAQ:334970)
South Korea · Delayed Price · Currency is KRW 3,235.00
+15.00 (0.47%)
At close: Dec 5, 2025
Prestige Biologics Market Cap
Prestige Biologics has a market cap or net worth of 251.53 billion as of December 5, 2025. Its market cap has decreased by -48.67% in one year.
Market Cap
251.53B
Enterprise Value
339.87B
Revenue
13.36B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,235.00
Market Cap Chart
Since March 11, 2021, Prestige Biologics's market cap has decreased from 613.27B to 251.53B, a decrease of -58.99%. That is a compound annual growth rate of -17.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 251.53B | -36.17% |
| Dec 30, 2024 | 394.06B | 46.25% |
| Dec 28, 2023 | 269.45B | 46.01% |
| Dec 29, 2022 | 184.55B | -59.28% |
| Dec 30, 2021 | 453.18B | -26.10% |
| Mar 11, 2021 | 613.27B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 709.49T |
| SK hynix | 375.61T |
| LG Energy Solution | 99.68T |
| Samsung Biologics | 75.96T |
| Hyundai Motor Company | 68.19T |
| Doosan Enerbility | 51.49T |
| HD Hyundai Heavy Industries | 47.40T |
| KB Financial Group | 47.22T |